In the first action of its kind, the SEC has temporarily suspended the Tier 2 Regulation A+ offering of Med-X, Inc. The $15 million continuous offering of common stock was qualified by the SEC on November 3, 2015. The SEC stated it temporarily suspended the offering because Med-X has not filed its annual report on Form 1-K as required by Rule 257.
